Sahajanand Medical Technologies IPO Allotment Status: Check on MUFG Intime, BSE, NSE

Sahajanand Medical Technologies IPO allotment is scheduled for October 21, 2026, following an overall subscription of 14.2x. Qualified Institutional Buyers (QIBs) led the demand with 34.696x subscription, followed by Non-Institutional Investors (NIIs) at 14.642x and retail investors at 3.03x.

With bids exceeding the shares available, not every applicant will receive an allotment. Investors can check their Sahajanand Medical Technologies IPO allotment status through BSE, NSE, or the registrar, MUFG Intime India, once the allotment is finalised.

Important Dates

How to Check Sahajanand Medical Technologies IPO Allotment Status?

Method 1: Check on BSE

Visit the BSE IPO allotment status page: https://www.bseindia.com/investors/appli_check

• Select Equity as the issue type.
• Choose Sahajanand Medical Technologies IPO from the available list.
• Enter your application number or PAN.
• Complete the required verification.
• Click Search to view your allotment status.

Method 2: Check on NSE

Visit the NSE IPO section: https://www.nseindia.com/invest/check-trades-bids-verify-ipo-bids

• Select the option to verify IPO bid or allotment details.
• Choose Sahajanand Medical Technologies from the available issues.
• Enter your PAN or application number as requested.
• Complete the verification process.
• Submit to check your application or allotment details once available.

Method 3: Check on MUFG Intime (Registrar)

Visit the MUFG Intime IPO allotment page: https://in.mpms.mufg.com/Initial_Offer/public-issues.html

• Select Sahajanand Medical Technologies IPO from the company dropdown.
• Choose your preferred search method, such as PAN, application number, or DP/Client ID.
• Enter the relevant details.
• Complete the verification.
• Submit to view your IPO allotment status.

MUFG Intime is the registrar responsible for processing the issue's allotment records. If the IPO does not appear immediately, investors can check again after the allotment data is published.

Sahajanand Medical Technologies IPO Subscription Details

Source: INDmoney 

• The IPO received 14.2x overall subscription, indicating strong demand for the available shares. Institutional investors showed the highest interest, with QIB subscription reaching 34.696x, meaning bids were received for nearly 35 times the shares reserved for this category.
• Non-Institutional Investors also participated strongly, subscribing 14.642x their reserved portion. Retail subscription was comparatively lower at 3.03x, although demand still exceeded the available retail shares by more than three times.
• For retail applicants, the key figure is 3.03x retail subscription, not the overall 14.2x. However, this does not translate directly into a 1-in-3 allotment probability, as the actual chances depend on the number of valid applications and the final allotment process.

What's Next After Sahajanand Medical Technologies IPO Allotment?

Once the allotment is finalised on October 21, successful applicants can check their allotted shares through MUFG Intime, BSE, or NSE.

Investors receiving an allotment are expected to have the shares credited to their demat accounts on October 22, 2026. Sahajanand Medical Technologies shares are scheduled to begin trading on the BSE and NSE on October 23, 2026.

For applicants who do not receive shares, the blocked application amount is expected to be released on October 22. Under the ASBA process, money remains blocked in the investor's bank account until allotment, with the applicable amount debited only for shares allotted.

Investors who miss the allotment can still evaluate the stock after listing. However, its market price may open above or below the IPO issue price of ₹344 per share, making valuation and business fundamentals important considerations before investing.

Final Word

Sahajanand Medical Technologies IPO's 14.2x overall subscription reflects strong investor interest, particularly among QIBs and NIIs. Retail demand was relatively moderate at 3.03x, but oversubscription means allotment is not guaranteed for every retail applicant.

For investors, the immediate priority is to check their allotment status on October 21 through MUFG Intime, BSE, or NSE. Those receiving shares should track the October 23 listing and assess the company's valuation, financial performance, and growth prospects rather than relying only on subscription numbers.

Investors who do not receive an allotment can evaluate the stock once it begins trading, when the actual market price provides a clearer basis for making an investment decision.

To prepare for listing day, read our guide on what to do after an IPO lists: sell, hold, or buy.

Read the RA disclaimer here.